Behzad M. Toosi

Prince Albert, SK, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells.

The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells.

Journal: Cancer cell international

Published: February 28, 2025

Vimentin as a contributing factor in SARS-CoV-2-induced orchitis on postmortem testicular autopsy of COVID-19 cases: A case-control study.

Vimentin as a contributing factor in SARS-CoV-2-induced orchitis on postmortem testicular autopsy of COVID-19 cases: A case-control study.

Journal: International journal of reproductive biomedicine

Published: July 13, 2024

The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells.

The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells.

Journal: Cells

Published: February 15, 2024

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

Journal: Cell genomics

Published: February 02, 2024

A Systematic Investigation into the Influence of Net Charge on the Biological Distribution of Radiometalated Peptides Using [68Ga]Ga-DOTA-TATE Derivatives.

A Systematic Investigation into the Influence of Net Charge on the Biological Distribution of Radiometalated Peptides Using [68Ga]Ga-DOTA-TATE Derivatives.

Journal: Bioconjugate chemistry

Published: February 17, 2023

Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR.

Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR.

Journal: Cell reports

Published: December 07, 2022

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 09, 2022

The EphB6 Receptor: Kinase-Dead but Very Much Alive.

The EphB6 Receptor: Kinase-Dead but Very Much Alive.

Journal: International journal of molecular sciences

Published: June 10, 2021

Prolonged acute intermittent hypoxia improves forelimb reach-to-grasp function in a rat model of chronic cervical spinal cord injury.

Prolonged acute intermittent hypoxia improves forelimb reach-to-grasp function in a rat model of chronic cervical spinal cord injury.

Journal: Experimental neurology

Published: January 07, 2021

Molecular characterization of an MLL1 fusion and its role in chromosomal instability.

Molecular characterization of an MLL1 fusion and its role in chromosomal instability.

Journal: Molecular oncology

Published: June 06, 2018

An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer.

An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer.

Journal: Molecular systems biology

Published: December 03, 2017

The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment.

The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment.

Journal: Scientific reports

Published: July 19, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026